General Information of This Antibody-drug Conjugate (ADC)
ADC ID
DRG0WPASO
ADC Name
KTN-0125
Synonyms
CDX-0125-TEI; KTN0125; KTN 0125
   Click to Show/Hide
Organization
Kolltan Pharmaceuticals, Inc.; Celldex Therapeutics, Inc.
Drug Status
Investigative
Indication
In total 1 Indication(s)
Neuroblastoma
Investigative
.
Antibody Name
Undisclosed
Antigen Name
ALK tyrosine kinase receptor (ALK)
 Antigen Info 
Payload Name
Undisclosed
Linker Name
Undisclosed